New Partnership Aims to Expand Access to AI-Driven Cancer Genomic Testing
The collaboration combines AI-based analysis tools with a next-generation sequencing system to support labs performing tumor and liquid biopsy testing.
Latest Articles
Editor's Top Picks
FDA Proposes Reclassifying Oncology Nucleic Acid–Based Tests from Class III to Class II
The proposed order would shift these test systems to Class II with special controls, replacing the current PMA requirement for companion diagnostics and related oncology assays.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
New ‘Ultra-Mild’ Sequencing Method Addresses DNA Methylation Testing Limitations
UMBS-seq preserves DNA integrity while maintaining accuracy for cancer biomarker detection in liquid biopsies and tissue samples.
Equipment & Supply Spotlight
Comprehensive Liver Health Management: Top Platforms for Health Care Organizations
Compare leading liver health management platforms that support early detection, streamline clinical workflows, and improve outcomes for patients with liver disease.
News, Know-How & Standards
Disease Detection & Understanding
Plasma pTau Shows Promise as Early Endpoint in Alzheimer’s Trials
New cross-trial analysis supports the biomarker's potential to predict clinical benefit, reinforcing biomarker-driven trial designs.
